William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
You know, we've had a really good history of integrating companies, and I'll let you know. If you look at J&J, we've bought a lot of companies, sold a lot of companies. I think the integration is...you know, this is a tribute to the people that came from the Pfizer consumer group and the J&J group...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
